MedTrace Logo

Study Bronchoalveolar Lavage Fluid Driven Pathogenic Diagnosis of Lower Respiratory Tract Infections

NCT02852070 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2017-04-14

No results posted yet for this study

Summary

Comparison of microbiological yield from Bronchoalveolar Lavage Fluid (BALF) for the two common-used volume bronchoalveolar lavages(60ml and 120ml)in patients with different types of lower respiratory tract infection.

Assessment of the safety of two common-used volume bronchoalveolar lavages(60ml and 120ml), including the incidence of hospital-acquired pneumonia within 14 days after bronchoscopy, and other bronchoalveolar lavage related adverse events.

Conditions

Interventions

PROCEDURE

bronchoalveolar lavage 120ml

120mL sterile saline solution instilled into the distal bronchial tree in 3 times

PROCEDURE

bronchoalveolar lavage 60ml

60mL sterile saline solution instilled into the distal bronchial tree in 3 times

Sponsors & Collaborators

  • Capital Medical University

    lead OTHER

Principal Investigators

  • Cao Bin, MD · China-Japan Friendship Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-01-31
Completion
2018-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02852070 on ClinicalTrials.gov